Beyond the perforin/granzyme axis and cytokine-mediated mechanisms, the functional diversity of CD8+ T-cell subsets within the CRC microenvironment has emerged as a determinant of clinical outcome. This evidence concerns the gene CD8A and colorectal carcinoma.